Data / Drug companies / Cephalosporin Antibacterial
Cephalosporin Antibacterial drugs: 29 drugs from 70 companies in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cephalosporin Antibacterial is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 589 products in this class from 70 companies, covering 29 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on October 1, 2026.
The request: Get every company that lists a Cephalosporin Antibacterial drug in the FDA NDC directory, with headquarters, website and size. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 70Companies
- 589Products
- 29Drugs by generic name
Drugs in the Cephalosporin Antibacterial class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Cephalexin | 184 | 36 |
| Cefdinir | 81 | 25 |
| Cefuroxime axetil | 41 | 17 |
| Cefadroxil | 40 | 15 |
| Ceftriaxone sodium | 44 | 12 |
| Cefazolin | 34 | 11 |
| Cefpodoxime proxetil | 29 | 11 |
| Ceftriaxone | 19 | 7 |
| Cefixime | 12 | 7 |
| Cefepime | 16 | 6 |
| Cefazolin sodium | 12 | 5 |
| Cefoxitin | 12 | 4 |
| Cefepime hydrochloride | 11 | 4 |
| Cefaclor | 5 | 4 |
| Ceftazidime | 9 | 3 |
| Cefoxitin sodium | 6 | 2 |
| Ceftaroline fosamil | 6 | 2 |
| Cefotaxime | 5 | 2 |
| Cefotetan | 4 | 2 |
| Cefuroxime | 6 | 1 |
| Cefotaxime injection | 2 | 1 |
| Cefotetan disodium | 2 | 1 |
| Cefuroxime and dextrose | 2 | 1 |
| Cefuroxime sodium | 2 | 1 |
| Cefiderocol sulfate tosylate | 1 | 1 |
| Ceftazidime, avibactam | 1 | 1 |
| Ceftobiprole medocaril sodium | 1 | 1 |
| Ceftolozane and tazobactam | 1 | 1 |
| Zidebactam dihydrate and cefepime hydrochloride | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 47 | capsule; powder, for suspension | Generic drugs (ANDA) | February 20, 2021 |
| NuCare Pharmaceuticals,Inc. | 41 | capsule; powder, for suspension | Generic drugs (ANDA) | March 1, 2023 |
| Bryant Ranch Prepack | 34 | capsule; for suspension | Generic drugs (ANDA) | February 20, 2021 |
| Hikma Pharmaceuticals USA Inc. | 32 | injection, powder, for solution; injection | Generic drugs (ANDA) | October 31, 2025 |
| WG Critical Care, LLC | 24 | injection, powder, for solution | Generic drugs (ANDA) | May 10, 2024 |
| Apotex Corp. | 21 | injection, powder, for solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | September 30, 2026 |
| Ascend Laboratories, LLC | 18 | tablet, film coated; capsule | Generic drugs (ANDA) | October 21, 2024 |
| Hospira, Inc. | 18 | injection, powder, for solution | Generic drugs (ANDA) | August 24, 2020 |
| Preferred Pharmaceuticals Inc. | 18 | capsule; powder, for suspension | Generic drugs (ANDA) | August 12, 2026 |
| Remedyrepack Inc. | 18 | capsule; tablet, film coated | Generic drugs (ANDA) | September 21, 2026 |
| Aurobindo Pharma Limited | 17 | powder, for suspension; capsule | Generic drugs (ANDA) | April 14, 2015 |
| Asclemed USA, Inc. | 14 | capsule; powder, for suspension | Generic drugs (ANDA) | September 7, 2023 |
| Lupin Pharmaceuticals, Inc. | 13 | powder, for suspension; capsule | Generic drugs (ANDA) | October 14, 2020 |
| Fresenius Kabi USA, LLC | 12 | powder, for solution; injection, powder, for solution | Generic drugs (ANDA) | July 15, 2011 |
| Redpharm Drug | 12 | tablet, film coated; capsule | Generic drugs (ANDA) | March 1, 2023 |
| Sagent Pharmaceuticals | 12 | injection, powder, for solution | Generic drugs (ANDA) | September 1, 2016 |
| Teva Pharmaceuticals USA, Inc. | 12 | powder, for suspension; capsule | Generic drugs (ANDA) | May 9, 2007 |
| B. Braun Medical Inc. | 11 | injection, solution; solution | New drug applications (NDA) | March 10, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 11 | capsule; tablet, film coated | Generic drugs (ANDA) | January 20, 2011 |
| Proficient Rx LP | 11 | capsule; injection, powder, for solution | Generic drugs (ANDA) | February 20, 2021 |
| Sandoz Inc | 11 | injection, powder, for solution; tablet, film coated | Generic drugs (ANDA) | May 28, 2008 |
| Direct_Rx | 10 | capsule; powder, for suspension | Generic drugs (ANDA) | September 24, 2024 |
| NorthStar Rx LLC | 9 | powder, for suspension; granule, for suspension | Generic drugs (ANDA) | April 25, 2013 |
| Advanced Rx of Tennessee, LLC | 8 | capsule; tablet, film coated | Generic drugs (ANDA) | January 16, 2026 |
| Qilu Pharmaceutical Co., Ltd. | 8 | injection, powder, for solution | Generic drugs (ANDA) | June 29, 2016 |
| Sportpharm LLC | 8 | injection, powder, for solution; capsule | Generic drugs (ANDA) | July 21, 2021 |
| Bryant Ranch Prepack | 7 | capsule; for suspension | Generic drugs (ANDA) | March 28, 2019 |
| Bryant Ranch Prepack | 7 | capsule; for suspension | Generic drugs (ANDA) | March 28, 2019 |
| Proficient Rx LP | 7 | powder, for suspension; capsule | Generic drugs (ANDA) | December 1, 2010 |
| Aurobindo Pharma Limited | 6 | powder, for suspension; capsule | Generic drugs (ANDA) | June 9, 2026 |
| Baxter Healthcare Corporation | 6 | injection, solution | New drug applications (NDA) | May 31, 2024 |
| PD-Rx Pharmaceuticals, Inc. | 6 | capsule; tablet, film coated | Generic drugs (ANDA) | January 20, 2011 |
| Rising Pharma Holdings, Inc. | 6 | tablet, film coated; powder, for suspension | Generic drugs (ANDA) | April 25, 2013 |
| American Health Packaging | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | June 26, 2023 |
| AvKARE | 5 | capsule | Generic drugs (ANDA) | April 24, 2026 |
| Civica, Inc. | 5 | injection, powder, for solution | Generic drugs (ANDA) | August 18, 2026 |
| Samson Medical Technologies LLC | 5 | injection, powder, for solution; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 1, 2018 |
| Chartwell RX, LLC | 4 | capsule; powder, for suspension | Generic drugs (ANDA) | February 28, 2018 |
| Coupler LLC | 4 | tablet; capsule | Generic drugs (ANDA) | April 28, 2026 |
| Cronus Pharma LLC | 4 | tablet, film coated; capsule | Generic drugs (ANDA) | June 11, 2007 |
| Golden State Medical Supply, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | May 18, 2022 |
| Hawaii Repack, Inc. | 4 | capsule | Generic drugs (ANDA) | June 4, 2012 |
| Major Pharmaceuticals | 4 | capsule; tablet, film coated | Generic drugs (ANDA) | October 27, 2025 |
| QPharma, Inc. | 4 | capsule | Generic drugs (ANDA) | January 20, 2011 |
| Allergan, Inc. | 3 | powder, for solution | New drug applications (NDA) | December 26, 2014 |
| Direct RX | 3 | capsule | Generic drugs (ANDA) | August 14, 2019 |
| Northwind Health Company, LLC | 3 | capsule | Generic drugs (ANDA) | November 26, 2025 |
| Proficient Rx LP | 3 | capsule; injection, powder, for solution | Generic drugs (ANDA) | June 30, 2017 |
| Rising Pharma Holdings, Inc. | 3 | granule, for suspension; tablet | Generic drugs (ANDA) | December 12, 2025 |
| SteriMax Inc. | 3 | powder, for solution; injection, powder, for solution | Unapproved drugs for a shortage | October 1, 2026 |
| Amici Pharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | December 21, 2022 |
| AvPAK | 2 | capsule | Generic drugs (ANDA) | September 15, 2014 |
| Carlsbad Technology, Inc. | 2 | capsule | Generic drugs (ANDA) | July 31, 2008 |
| Henry Schein, Inc. | 2 | injection, powder, for solution | Generic drugs (ANDA) | January 9, 2022 |
| Medical Purchasing Solutions, LLC | 2 | injection, powder, for solution | Generic drugs (ANDA) | June 30, 2017 |
| PD-Rx Pharmaceuticals, Inc. | 2 | capsule | Generic drugs (ANDA) | September 30, 1990 |
| Pai Holdings, LLC DBA Pai Pharma | 2 | injection, powder, for solution | New drug applications (NDA) | April 8, 2024 |
| Pharma-C, Inc. | 2 | capsule | Generic drugs (ANDA) | October 15, 2010 |
| Amella Pharma, LLC | 1 | capsule | Generic drugs (ANDA) | June 27, 2018 |
| Asclemed USA Inc. | 1 | capsule | Generic drugs (ANDA) | May 9, 2007 |
| Azorian Pharma, LLC | 1 | suspension | Generic drugs (ANDA) | November 1, 2022 |
| BluePoint Laboratories | 1 | capsule | Generic drugs (ANDA) | August 1, 2018 |
| Health Department, Oklahoma State | 1 | capsule | Generic drugs (ANDA) | October 12, 2018 |
| La Jolla Pharmaceutical Company | 1 | injection, powder, for solution | New drug applications (NDA) | April 1, 2025 |
| Merck Sharp & Dohme LLC | 1 | injection, powder, lyophilized, for solution | New drug applications (NDA) | December 19, 2014 |
| NuCare Pharmaceuticals, Inc. | 1 | powder, for suspension | Generic drugs (ANDA) | September 30, 1990 |
| ProPharma Distribution | 1 | injection, powder, for solution | Generic drugs (ANDA) | June 30, 2017 |
| Shionogi Inc. | 1 | injection, powder, for solution | New drug applications (NDA) | January 31, 2020 |
| Unit Dose Solutions, Inc. | 1 | capsule | Generic drugs (ANDA) | September 30, 1990 |
| Wockhardt Suisse USA LLC | 1 | injection, powder, for solution | New drug applications (NDA) | May 29, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 226 | 38.4% |
| Injection, powder, for solution | 160 | 27.2% |
| Powder, for suspension | 58 | 9.8% |
| Tablet, film coated | 51 | 8.7% |
| For suspension | 28 | 4.8% |
| Tablet | 21 | 3.6% |
| Injection, solution | 14 | 2.4% |
| Powder, for solution | 12 | 2% |
| Injection, powder, lyophilized, for solution | 7 | 1.2% |
| Granule, for suspension | 6 | 1% |
| Solution | 3 | 0.5% |
| Tablet, film coated, extended release | 1 | 0.2% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.